Has Jignesh Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,717,030 in general payments to Jignesh Shah, MD across 909 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jignesh Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jignesh Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jignesh Shah, MD

Gastroenterology · Houston, TXNPI 1063550291

Payments from drug & device makers

$1,717,030in general payments, 2019–2025

Across 909 payments — averaging $1888.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Braintree Laboratories, Inc.$678K
Bausch Health US, LLC$257K
Pfizer$209K
Eli Lilly$175K
AbbVie$128K
Evoke Pharma, Inc.$102K
plus $167K from 32 others

$27,643in research payments, 2019–2025

Across 7 payments — averaging $3948.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$26K
Teva Pharmaceuticals USA, Inc.$624
Transmedics, Inc.$556

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Braintree Laboratories, Inc.	32	$678,349
Bausch Health US, LLC	116	$257,335
Pfizer(2 entities)	55	$208,656
Eli Lilly	13	$174,782
AbbVie	114	$128,477
Evoke Pharma, Inc.	102	$102,199
Sanofi US Services Inc.	7	$91,577
Teva Pharmaceuticals USA, Inc.	7	$47,310
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	190	$19,435
Ardelyx, Inc.	33	$2,097
Redhill Biopharma Inc.	27	$2,059
Takeda Pharmaceuticals U.S.A., Inc.	70	$1,490
Madrigal Pharmaceuticals	32	$481
QOL Medical, LLC	3	$413
Ironwood Pharmaceuticals, Inc	25	$398
Johnson & Johnson(2 entities)	20	$360
Bristol Myers Squibb	19	$332
Merck	11	$229
Gilead	7	$156
Inari Medical, Inc.	1	$140
Sanofi	4	$111
Silk Road Medical, Inc.	1	$97
Pulmonx Corporation	1	$92
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$74
Lilly USA, LLC	2	$53
Enterra Medical, Inc.	1	$53
Medtronic(2 entities)	2	$41
Shionogi Inc	1	$33
Conmed Corporation	1	$29
Fujifilm Healthcare Americas Corporation	1	$27
Boston Scientific	1	$26
Ambu Inc.	1	$25
Inspire Medical Systems, Inc.	1	$23
Axonics, Inc.	1	$23
Intercept Pharmaceuticals, Inc.	1	$19
Romark Laboratories, LC	1	$14
Cook Medical LLC	1	$12
Gastrogpo, LLC	3	$0

How this compares

$1,717,030 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024

$171,943

Medicare patients

307

Services billed

3,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Houston

Mazen NoureddinHouston$6.1M
James MaherHouston$5.3M
Uma MohanHouston$5M
John VierlingHouston$2.8M
Bincy AbrahamHouston$2.5M
Jason HouHouston$2.3M
Mouhamad Al-SabbaghHouston$1.6M
Mohamed OthmanHouston$1.6M
Harry OjeasHouston$1.5M
Stephen PappasHouston$1.4M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →